Navigation Links
Neuralstem Updates ALS Stem Cell Trial Progress
Date:5/8/2012

ROCKVILLE, Md., May 8, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that the Federal Drug Administration (FDA) has approved the return of three patients from earlier cohorts in its ongoing Phase I safety trial to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) with its spinal cord stem cells (HSSC's). These patients will be permitted to return to the trial for second treatments as the next cohort of patients, provided they meet inclusion requirements at the scheduled time. They will be the first to receive stem cell transplantation along the length of the spinal cord.

(Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO )

The first twelve patients in the trial, which is taking place at Emory University Hospital in Atlanta, Georgia, received stem cell transplants in the lumbar (lower back) region of the spinal cord only. The last cohort of three, completed in April, received transplants in the cervical (upper back) region of the spinal cord, where stem cell transplantation could help support breathing, a key function that is lost as ALS progresses. The next cohort of three patients is designed to receive 10 HSSC injections in the lumbar region and 5 in the cervical, for a total of 15 injections along the length of the spinal cord.  In the case of the returning patients, who have already received 10 lumbar injections, they will receive five cervical injections. These patients are between 15-17 months out from their first dosing and appear to have tolerated the first procedure well.

Additionally, Neuralstem has submitted a trial amendment to the FDA to increase both the number of patients treated as well as the dose in future cohorts. The amendment would also expand the trial to include certain efficacy endpoints. The trial was initiall
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Neuralstem Announces Issuance of Core Technology Patent in Europe
2. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
3. Neuralstems ALS Trial on Clinical Hold
4. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
5. Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
6. Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
7. Neuralstem Updates ALS Clinical Trial Progress
8. Dr. Eva Feldman, Principal Investigator, Presents Interim Safety Results for Neuralstem ALS Trial
9. Neuralstem Updates NSI-189 Major Depression Trial
10. Neuralstem Announces Notice of Allowance for Two Additional Neurogenic Compound Patents
11. Dr. Eva Feldman, Principal Investigator, Presents Interim Data on Neuralstem ALS Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... -- Prostate cancer is the second leading cause of cancer ... caught early - the problem is that too often ... Conditions Education Council (PCEC), – a national organization ... cancer screening –  is sponsoring its 25 th ... Committed to encouraging men to take ...
(Date:9/22/2014)... , Sept. 22, 2014 CytRx Corporation ... development company specializing in oncology, today announced that study ... clinical trials of aldoxorubicin, a pivotal global Phase 3 ... a global Phase 2b clinical trial in small cell ... for Medical Oncology (ESMO) 2014 Congress being held September ...
(Date:9/19/2014)... CHAPEL HILL, N.C. , Sept. 19, 2014 ... critical role in forging relationships with key opinion ... the market and competition. Despite the critical nature ... has created many challenges, including altering the landscape ... According to research, the oversight ...
Breaking Medicine Technology:PCEC Encourages Men Across America to Have a Baseline Prostate Health Assessment During the Annual Prostate Cancer Awareness Week 2PCEC Encourages Men Across America to Have a Baseline Prostate Health Assessment During the Annual Prostate Cancer Awareness Week 3CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 2CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 3CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 4CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 5CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 6Role of Medical Science Liaisons Shifting in Healthcare Industry 2
... Philips Respironics applauds the efforts of the Centers ... about an important public health issue -- chronic sleep ... to monitor state-by-state differences in sleeplessness is a milestone ... , As a long-time educator, industry leader and ...
... 6 Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) will hold ... EST to discuss the third quarter 2009 financial results and business ... Officer of the Company, will host the call. Keryx will ... to be issued prior to the call. , In order to ...
Cached Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2
(Date:9/22/2014)... 2014 The report segments the ... user, and geography. The equipment segment accounted for ... market, by product. However, the accessories segment is ... the forecast period, owing to the rising demand ... and ultrasound segments are the fastest-growing segments in ...
(Date:9/22/2014)... participate in athletics will be asked to sign a ... ensure parents are confident about handling the injury, according ... Hospital National Poll on Children,s Health. , In the ... and high school children surveyed reported participation in some ... read a brochure or online information, 17% have ...
(Date:9/22/2014)... and leadership of Senators Sherrod Brown (D-Ohio) and ... primary care services were lauded yesterday by the ... organizations, representing internal medicine and related subspecialties. ... for introducing the Ensuring Access to Primary Care ... will extend current-law payment rates under Medicaid for ...
(Date:9/22/2014)... 2014) The success of a colonoscopy is closely ... often resulting in missed precancerous lesions, according to new ... on Colorectal Cancer. Additionally, poor bowel cleansing can result ... to 20 to 25 percent of all colonoscopies are ... "When prescribing bowel preparation for their patients, health-care professionals ...
(Date:9/22/2014)... laser weapons, the Office of Naval Research (ONR) this ... Day Marine exposition that will prepare Marines as they ... ONR program officers will be in Booth No. 2305 ... Base Quantico, to discuss how their research contributes to ... austere and lethal." , ONR,s Expeditionary Maneuver Warfare and ...
Breaking Medicine News(10 mins):Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 2Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 3Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 4Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 5Health News:Some concussion education more useful than others, parents say 2Health News:Broad physician coalition urges Congress to extend Medicaid pay parity 2Health News:Good bowel cleansing is key for high-quality colonoscopy 2Health News:Good bowel cleansing is key for high-quality colonoscopy 3Health News:Modern Day Marine: ONR features technology for marines of the future 2
... CREEK, Calif., March 7 Longs Drug,Stores Corporation ... J. Vasos has been,named executive vice president and ... who has left the Company. Vasos will,be responsible ... Vasos joined Longs in 2001 as senior ...
... available in Spanish . , Researchers from the ... the University of Granada have carried out a ... come to is that an efficient response in primary care ... caused by three of the most frequent pathologies in older ...
... health care to be released at forum, LOS ... MAYA:, What: MAYA along with leading business and ... Better Through Communication" to,seek new ways to promote better ... and the Latino Issues Forum will release the,findings of ...
... IPC The,Hospitalist Company, Inc. (Nasdaq: IPCM ), a ... hospitalist medicine services,announced today that it will report results ... 20, 2008, before the market opens., A conference ... a.m. ET,(6:00 a.m. PT) on March 20, 2008 and ...
... Western Reserve University School of Medicine researchers published a ... Journal of Human Genetics identifying the hereditary components of ... in a Genome-wide Scan: Results from the Colon Neoplasia ... families with CRC and colon polyps in the country. ...
... physical, mental scores, study finds , , FRIDAY, March 7 ... families boosts children,s physical and mental development, a U.S. ... California, Berkeley found that children in low-income families in ... a government-run conditional cash transfer program were taller, less ...
Cached Medicine News:Health News:Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer 2Health News:An efficient response in primary care would reduce the use of hospitals by elderly people 2Health News:Nationwide Telephone News Briefing for U.S. Health Disparities Forum 2Health News:IPC The Hospitalist Company, Inc. to Report Fourth Quarter and Year-End 2007 Financial Results 2Health News:Case Western Reserve University researchers identify colorectal cancer gene 2Health News:Government Assistance Linked to Better Child Development 2
... dedicated to the principles of excellence and ... committed to aiding the clinician in early ... design of profiles and panels that provide ... tests. These tests assist to resolve the ...
ChildLab is a service of Children's Hospital, Columbus Ohio...
Millenova Immunology Laboratories is a reference laboratory dedicated to the diagnosis of immunologic causes of reproductive failure, infertility and recurrent pregnancy loss....
Marquette General Health System Reference Laboratory provides a full range of testing including, Chemistry, Hematology, Coagulation, Urinalysis, Microbiology, Cytology, Anatomic Pathology, Flow Cytom...
Medicine Products: